The transaction is sourced from an SEC EDGAR filing, specifically a Form 8-K published on June 24, 2024. As of the information provided, the deal's status is pending regulatory approval.
On the financial advisory side, J.P. Morgan is acting as the exclusive financial advisor to Bunge and is identified as the lead advisor on the target side of the transaction. The source language states that J.P. Morgan is acting as exclusive financial advisor to Bunge, which also specifies the legal counsel involved. No financial advisor to BP, the acquirer of the stake, is identified in the facts provided.
On the legal side, Tauil & Chequer Advogados, associated with Mayer Brown, is serving as legal counsel to Bunge (the target side of the transaction). No legal advisor is identified for BP in the material provided.
Beyond the identification of BP as acquirer of the 50 percent joint-venture stake and Bunge as the counterparty, no further detail on deal structure, such as the form of consideration or any financing arrangements, is included in the facts available.
Several elements of this deal are not disclosed in the available material. No expected closing date is given, no outside legal or financial advisor to BP is identified, and no additional structural or financing terms beyond the headline value of 800,000,000 dollars are specified. The current status is pending regulatory approval, with no further detail on the specific regulatory approvals required or an anticipated timeline to completion.